doi: 10.3389/fneur.2024.1356662 Received 15 December 2023 Accepted 10 May 2024 Published 19 June 2024 Volume 15 - 2024 Edited by Dominic D'Agostino, University of South Florida, United States Reviewed by Anandakumar Shunmugavel, Case Western Reserve University, United States Xuehua Liu, Capital Medical University, China Updates Copyright 2024 Fogarty and Harch
Heres what we do know from the few human reports available, and why they offer limited reassurance: Phase I trial (unpublished): In 2015, a formal Phase I trial on 42 healthy volunteers was initiated to assess BPC-157s safety and pharmacokinetics
Limited research on side effects : Few studies have explored BPC 157's potential negative effects, and its full range of effects is not well understood
Safety vs
Bilateral carotid sinus nerve transection exacerbates morphine-induced respiratory depression
Heavy metal stress signaling in plants, in ed.AhmadP